MIMEDX to Highlight Published Data at SAWC Fall
02 11월 2023 - 9:00PM
MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today
announced it will sponsor an Innovation Theater lunch symposium at
the Symposium on Advanced Wound Care (SAWC) Fall meeting taking
place November 2-5 in Las Vegas, NV. In addition, the Company will
participate in the conference’s exhibition at booth number 511.
In the session, Drs. Mouawad, Tettelbach, and
Wahab will review recent data examining the clinical and economic
impacts of using skin substitutes in the treatment of Venous Leg
Ulcers (“VLUs”) as well as published data evaluating the impact of
adequate debridement in the treatment algorithm of chronic wounds
and how it translates to clinical outcomes. These faculty
presenters will also discuss their clinical experiences with the
Company’s recently launched tri-layer placental allograft,
EPIEFFECT®.
Sponsored Lunch Symposium
Bringing the Data into Focus: Optimizing
Clinical Outcomes and Cost-Effectiveness in the Treatment of Venous
Leg Ulcers
Date/Time: Friday, November 3 / 11:40 a.m. –
1:10 p.m. PDT
Faculty Presenters:
- Nicolas Mouawad, MD, MPH, MBA,
RPVI, FRCS, FACS, FSVS
- William H. Tettelbach, MD, FACP,
FIDSA, FUHM, CWS
- Naz Wahab, MD, FAAFP, FAPWCA
Accepted Poster
Presentations
The Company is pleased to announce that nine
clinical and scientific posters have been accepted and will be on
display in the poster hall. This effort further reinforces the
MIMEDX commitment to clinical and scientific evidence and continues
to add to the robust portfolio of published evidence supporting the
use of Purion® processed human placental allografts.
Clinical:
1. Dehydrated Human Amnion Chorion
Membrane (DHACM) Use in Patients with Emergent Craniectomies
Demonstrates Minimal Dural Adhesions at Time of Cranioplasty
2. Dehydrated Human Amnion Chorion
Membrane Allograft for the Management of Hard to Heal Complex
Wounds
3. Challenging Heel Defect and Skin
Graft Utilizing Dehydrated Human Amnion/Chorion Membrane and
Negative Pressure Wound Therapy
4. Fifth Ray Amputation with
Application of Placental Extracellular Matrix (PECM) and Secondary
Closure Observed
5. Limb Salvage in a Complex Patient
Undergoing Multiple Lower Extremity Amputations with Placental
Extracellular Matrix (PECM)
6. The Use of Lyophilized, Tri-layer
Human Amnion/Chorion Membrane (LHACM) as a Barrier Membrane in
Patients Undergoing Lapiplasty 3D Bunion Correction Surgery
7. Traumatic Lower Extremity Wound
from Motor Vehicle Accident Treated with Dehydrated Human Umbilical
Cord and Dehydrated Human Amnion/Chorion Membrane
8. First Reported Use of Lyophilized
Human Amnion Chorion Membrane (LHACM) in the Treatment of a
Diabetic Foot Ulcer in a Charcot Patient
Research:
9. Evaluation of Two Purion Processed
Amniotic Tissue Allografts: Bioactivity with Targeted Structural
Distinctions
About SAWC FallThe Symposium on
Advanced Wound Care (SAWC) Fall serves as a forum to connect the
entire wound care team—physicians, nurses, physical therapists,
researchers, scientists, podiatrists, and dietitians—with the
foremost experts in wound care to improve patient outcomes through
education. No other wound care conference offers this level of
education, advanced state-of-the art clinical reviews, and emerging
research findings. The meeting is organized by HMP Global, an
omnichannel leader in healthcare events and education with a
mission to improve patient care.
About MIMEDXMIMEDX is a pioneer
and leader focused on helping humans heal. With more than a decade
of helping clinicians manage chronic and other hard-to-heal wounds,
MIMEDX is dedicated to providing a leading portfolio of products
for applications in the wound care, burn, and surgical sectors of
healthcare. The Company’s vision is to be the leading global
provider of healing solutions through relentless innovation to
restore quality of life. For additional information, please visit
www.mimedx.com.
Contact:Matt NotarianniInvestor
Relations470-304-7291mnotarianni@mimedx.com
MiMedx (NASDAQ:MDXG)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
MiMedx (NASDAQ:MDXG)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024